NEW YORK (GenomeWeb) - WaferGen Bio-systems reported after the close of the market on Tuesday that its second quarter revenues rose 56 percent, driven by an increase in product revenues.

For the three months ended June 30, the company reported revenues of $2.5 million, up from $1.6 million in the prior-year period. Product revenues accounted for all recorded revenues, rising 70 percent, primarily attributable to increases in sales of its SmartChip NGS target enrichment system. The firm did not record any license and royalty revenue in the quarter.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.